|55 Kenosia Avenue
Danbury, CT 06810
Toll Free: 1.800.999.6673
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
The information in NORD’s Rare Disease Database is for educational purposes only. It should never be used for diagnostic or treatment purposes. If you have questions regarding a medical condition, always seek the advice of your physician or other qualified health professional. NORD’s reports provide a brief overview of rare diseases. For more specific information, we encourage you to contact your personal physician or the agencies listed as “Resources” on this report.
Copyright 1996, 2002
Oculocerebral Syndrome with Hypopigmentation is an extremely rare inherited disorder characterized by the lack of normal color (hypopigmentation) of the skin and hair and abnormalities of the central nervous system that affect the eyes and certain parts of the brain (oculocerebral). Physical findings at birth include unusually light skin color and silvery-gray hair. Abnormal findings associated with the central nervous system may include abnormal smallness of one or both eyes (microphthalmia); clouding (opacities) of the front, clear portion of the eye through which light passes (cornea); and/or rapid, involuntary eye movements (nystagmus). Additional symptoms that may develop during infancy include involuntary muscle contractions, associated loss of muscle function (spastic paraplegia), developmental delays, and/or mental retardation. Oculocerebral Syndrome with Hypopigmentation is believed to be inherited as an autosomal recessive genetic trait.
Oculocerebral Syndrome with Hypopigmentation, also known as Cross Syndrome, is an extremely rare inherited disorder that may be apparent at birth (congenital) or during early infancy. The first visible signs of the disorder are decreased color (hypopigmentation) or total lack of color (depigmentation) of the skin and hair. The skin is usually very light and may be extremely sensitive to exposure to the sun. In most cases, the hair is often silvery or silvery-gray in color at birth. In addition, infants with Oculocerebral Syndrome with Hypopigmentation may be abnormally sensitive to light (photosensitivity).
Later during infancy, affected infants may begin to exhibit more serious abnormalities. By three months of age, an infant with Oculocerebral Syndrome with Hypopigmentation may exhibit symptoms associated with abnormalities of the central nervous system (i.e., affecting parts of the brain and the eyes). These symptoms may include slow involuntary purposeless movements of various muscles, especially those in the hands (athetoid movements); impaired ability to coordinate voluntary movements (ataxia); movement of the head beyond the normal range of motion (hyperextension), and/or increased rigidity in some muscles causing stiffness and limitation of movement. In more severe cases, children may experience lack of voluntary movements of the arms and legs (spastic tetraplegia). Other neurological symptoms may include exaggerated reflexes and/or fixation of several joints in a permanently flexed position (joint contractures). The legs, arms, shoulders, and hips are the sites that are most often involved. Affected individuals may also have a high-pitched cry or make constant sucking sounds.
Infants with Oculocerebral Syndrome with Hypopigmentation may also have abnormalities of the eyes including abnormal smallness of one or both eyes (microphthalmia). In some cases, the front clear portion of the eyes through which light passes (corneas) may also be unusually small (microcornea). Affected infants may also exhibit abnormal clouding (opacity) of the corneas; rapid side-to-side involuntary eye movements (horizontal nystagmus); an outward turning of the eyelids, exposing the delicate membranes that line the inside of the eyelids (ectropion palpebral conjunctivae); loss of transparency (opacity) of the lenses of the eyes (cataracts); and/or wasting away (atrophy) of the iris and/or the optic nerve (optic atrophy). Such eye abnormalities may result in varying degrees of visual impairment or, in some cases, blindness. The degree of visual impairment depends upon the severity and/or combination of eye abnormalities present.
Children with Oculocerebral Syndrome with Hypopigmentation may also exhibit mental retardation, abnormally slow physical development (growth retardation), a delay in reaching developmental milestones (e.g., holding up their heads, sitting, walking, etc.), and/or a delay in the acquisition of skills requiring the coordination of muscular and mental activity (psychomotor retardation).
Between the ages of six months to three years, when the baby teeth emerge from the gums, most infants with this disorder may develop abnormally large gums (gingival fibromatosis). The overgrown gums may be pink and leathery and have small pebble-like bumps on the surface. In rare cases, the gums may completely cover the teeth and protrude from the mouth. If not corrected, enlargement of the gums may cause speech problems, or in severe cases, may interfere with breathing and swallowing.
Other findings in children with Oculocerebral Syndrome with Hypopigmentation may include an abnormally long appearance to the head (dolichocephaly), a highly-arched roof of the mouth (palate), widely spaced teeth, and/or underdevelopment of a muscle (diaphragm) that is necessary for proper breathing (oligophrenia). Oligophrenia may cause respiratory difficulties. In one case reported in the medical literature, urinary tract abnormalities were present.
Oculocerebral Syndrome with Hypopigmentation is believed to be inherited as an autosomal recessive genetic trait. Human traits, including the classic genetic diseases, are the product of the interaction of two genes, one received from the father and one from the mother.
In recessive disorders, the condition does not appear unless a person inherits the same defective gene for the same trait from each parent. If an individual receives one normal gene and one gene for the disease, the person will be a carrier for the disease, but usually will not show symptoms. The risk of transmitting the disease to the children of a couple, both of whom are carriers for a recessive disorder, is 25 percent. Fifty percent of their children risk being carriers of the disease, but generally will not show symptoms of the disorder. Twenty-five percent of their children may receive both normal genes, one from each parent, and will be genetically normal (for that particular trait). The risk is the same for each pregnancy.
Parents of several individuals with the disorder have been closely related by blood (consanguineous). In these cases, there is a higher than normal chance that both parents carry, and consequently may pass on, the genes necessary for development of the disorder.
Oculocerebral Syndrome with Hypopigmentation is an extremely rare disorder that affects males and females in equal numbers. Fewer than 15 cases have been reported in the medical literature. Most of these observed cases occurred within families.
Abnormally small eyes and lack of skin and hair color are usually apparent at birth (congenital). Neurological abnormalities (e.g., athetoid movements, ataxia, etc.) may become apparent by three months of age. Some affected infants exhibit abnormally enlarged gums (gingival fibromatosis) when the first teeth emerge from the gums (at age six months to three years). Other symptoms (e.g., developmental delays, mental retardation, etc.) may become apparent later during infancy or childhood.
Symptoms of the following disorders can be similar to those of Oculocerebral Syndrome with Hypopigmentation. Comparisons may be useful for a differential diagnosis:
Chediak-Higashi Syndrome is a rare inherited disorder characterized by the lack of normal color of the skin and eyes (oculocutaneous albinism), visual difficulties, and/or abnormalities affecting certain white blood cells (leukocytes) that may result in immune system deficiencies. The hair is typically blond or light brown with a silvery tint. Affected infants may also exhibit abnormal sensitivity to light (photosensitivity), rapid involuntary eye movements (nystagmus), and/or an impaired ability to coordinate voluntary movements (ataxia). Chediak-Higashi Syndrome is inherited as an autosomal recessive genetic trait. (For more information on this disorder, choose "Chediak Higashi" as your search term in the Rare Disease Database.)
Hermansky-Pudlak Syndrome is a rare inherited disorder characterized by: lack of normal skin pigmentation (albinism), blood platelet dysfunction with prolonged bleeding, visual impairment, and abnormal storage of a fatty-like substance in various tissues of the body. In individuals with Hermansky-Pudlak Syndrome, the skin, hair, and eyes may vary in color from very pale to almost normal coloring. Other symptoms of Hermansky-Pudlak Syndrome may include easy bruising, bleeding gums, and excessive bleeding after surgery or accidents. Hermansky-Pudlak Syndrome is inherited as an autosomal recessive genetic trait. (For more information on this disorder, choose "Hermansky Pudlak" as your search term in the Rare Disease Database.)
Albinism is a group of rare inherited disorders characterized by decreased color (hypopigmentation) or complete absence of color (depigmentation) in the skin, hair, and eyes at birth. Albinism may be associated with many different syndromes. In individuals with Albinism, the skin and the eyes are generally extremely pale or white. This may result in abnormal sensitivity to light, abnormal eye movements, crossed eyes, and/or nearsightedness (myopia). Some people with Albinism may be at an increased risk of developing skin cancer. The range and severity of symptoms and physical characteristics associated with Albinism depend upon the type of Albinism present. (For more information on this disorder, choose "Albinism" as your search term in the Rare Disease Database.)
Menkes Disease is a rare genetic disorder of copper metabolism beginning before birth. Copper accumulates in excessive amounts in the liver, and is deficient in most other tissues of the body. Structural changes occur in the hair, brain, bones, liver and arteries. Physical findings may include poorly pigmented, frail hair and lack of normal skin color (hypopigmentation). (For more information on this disorder, choose "Menkes" as your search term in the Rare Disease Database.)
The diagnosis of Oculocerebral Syndrome with Hypopigmentation may be confirmed based upon a thorough clinical evaluation and detailed patient history, characteristic physical findings, specialized laboratory tests, imaging techniques, and/or genetic testing. Oculocerebral Syndrome with Hypopigmentation may be suspected in infants with characteristic neurological and ocular abnormalities occurring in association with the presence of abnormally light skin and silvery-gray hair.
Abnormal lack of skin color (cutaneous hypopigmentation) and abnormally small eye(s) are usually obvious at birth or in early infancy. Ultrasonography may be used to confirm a diagnosis of microphthalmia. Ultrasonography, a testing method that creates an image of internal structures by measuring the reflection of sound waves, may demonstrate that the length from the front to the back of the eye (anteroposterior axis) is smaller than normal (microphthalmia). Horizontal side-to-side eye movements (nystagmus) and outward turning of the eyelids (ectropion palpebral conjunctivae) may also be observed at birth. Enlarged gums (gingival fibromatosis) may develop when the first teeth emerge from the gums (usually around six months to three years of age). Neurological abnormalities, such as athetoid movements and ataxia, may become apparent around three months of age. Other symptoms (e.g., developmental delays, mental retardation, etc.) may not become apparent until late infancy or childhood.
Internal abnormalities such as an underdeveloped diaphragm (oligophrenia) may be detected through a combination of observation and internal imaging techniques, such as computerized tomography (CT) scanning. CT scanning is an imaging technique in which a computer and x-rays are used to create a film showing cross-sectional images of certain organs.
The treatment of Oculocerebral Syndrome with Hypopigmentation is directed toward the specific symptoms that are apparent in each individual. Treatment may require the coordinated efforts of a team of specialists. Pediatricians, dentists, physicians who specialize in disorders of the eyes (ophthamologists), physicians who specialize in skin disorders (dermatologists), and other health care professionals may need to systematically and comprehensively plan an affected child's treatment.
Specific therapies for the treatment of Oculocerebral Syndrome with Hypopigmentation are symptomatic and supportive. Due to lack of normal skin color, an affected child's skin may be highly sensitive to sun exposure; therefore, sunscreen, hats, and long sleeves may be recommended to avoid sunburn. Wearing sunglasses and other preventative measures may also be recommended to protect affected individuals from the sun.
Corrective glasses or contact lenses may be used to help improve vision. In some cases, eye surgery may be performed.
The size of the gums may be reduced with surgery. However, the enlargement may recur as more teeth emerge and/or when secondary teeth grow in, requiring subsequent surgery.
Early intervention is important to ensure that affected children with Oculocerebral Syndrome with Hypopigmentation reach their potential. Special services that may be beneficial to affected children may include special remedial education and other medical, social, and/or vocational services.
Research on genetic disorders and their causes is ongoing. The National Institutes of Health (NIH) is sponsoring the Human Genome Project which is aimed at mapping every gene in the human body and learning why they sometimes malfunction. It is hoped that this new knowledge will lead to prevention and treatment of genetic and familial disorders in the future.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Please note that some of these organizations may provide information concerning certain conditions potentially associated with this disorder (e.g., visual handicaps, neurological abnormalities, etc.).
PO Box 8126
Gaithersburg, MD 20898-8126
Phone #: 301-251-4925
800 #: 888-205-2311
Home page: http://rarediseases.info.nih.gov/GARD/
111 E 59th St
New York, NY 10022-1202
Phone #: N/A
800 #: 800-829-0500
Home page: http://www.lighthouse.org
P.O. Box 317
Watertown, MA 02272-0317
Phone #: 617-972-7441
800 #: 800-562-6265
Home page: http://www.napvi.org
31 Center Dr
Bethesda, MD 20892-2510 United States
Phone #: 301-496-5248
800 #: --
Home page: http://www.nei.nih.gov/
One AMS Circle
Bethesda, MD 20892-3675 USA
Phone #: 301-495-4484
800 #: 877-226-4267
Home page: http://www.niams.nih.gov/
Scriver CR, et al., eds. The Metabolic and Molecular Basis of Inherited Disease. 7th Ed. New York, NY; McGraw-Hill Companies, Inc; 1995:4379.
Champion RH, et al., eds. Textbook of Dermatology. 5th ed. Cambridge, MA: Blackwell Scientific Publications; 1992:1605, 2668, 2705.
Buyce ML, ed. Birth Defects Encyclopedia. Dover, MA: Blackwell Scientific Publications; For: The Center for Birth Defects Information Services Inc; 1990:81, 660-62, 775, 778-79.
Tezcan I, et al. A new case of oculocerebral hypopigmentation syndrome (Cross syndrome) with additional findings. Clin Genet. 1997;51:118-21.
Lerone M, et al. Oculocerebral syndrome with hypopigmentation (Cross syndrome): report of a new case. Clin Genet. 1992;41:87-89.
De Jong G, et al. Oculocerebral syndrome with hypopigmentation (Cross syndrome): the mixed pattern of hair pigmentation as an important diagnostic sign. Genet Couns. 1991;2:151-55.
Ozkan H. Oculocerebral hypopigmentation syndrome (Cross syndrome). Turk J Pediatr. 1991;33:247-52.
Courtens W, et al. Oculocerebral hypopigmentation syndrome (Cross syndrome) in a gipsy child. Acta Pediatr Scand. 1989;78:806-10.
Castle DJ, et al. The oculocerebral syndrome in association with generalised hypopigmentation. A case report. S Afr Med J. 1989;76:35-56.
Fryns JP, et al. Oculocerebral syndrome with hypopigmentation (Cross syndrome). Report of two siblings born to consanguineous parents. Clin Genet. 1988;34:81-84.
Patton MA, et al. An oculocerebral hypopigmentation syndrome: a case report with clinical, histochemical, and ultrastructural findings. J Med Genet. 1987;24:118-22.
Preus M, et al. An oculocerebral hypopigmentation syndrome. J Genet Hum. 1983;31:323-28.
Cross HE, et al. A new oculocerebral syndrome with hypopigmentation. J Pediatr. 1967;70:398-406.
FROM THE INTERNET
McKusick VA, ed. Online Mendelian Inheritance in Man (OMIM). Baltimore. MD: The Johns Hopkins University; Entry No: 257800; Last Update:5/1/97.
Report last updated: 2008/04/24 00:00:00 GMT+0